Mechanistically, we identified nexilin (NEXN) as the direct target of CLK4 and the reduction of phosphorylated NEXN mediated the development of pathological myocardial hypertrophy and heart failure in Clk4-cKO mice. Here, CLK4 is linked to cardiac hypertrophy.